Literature DB >> 8414709

Necrotizing enterocolitis. New thoughts about pathogenesis and potential treatments.

W MacKendrick1, M Caplan.   

Abstract

Necrotizing enterocolitis (NEC) remains a major cause of morbidity and mortality in premature infants. An incomplete understanding of its pathogenesis has hampered efforts to devise an effective preventative strategy. New insights into the pathogenesis of NEC, particularly at the cellular and biochemical level, however, offer a rational basis for the development of new approaches to this disease.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8414709     DOI： 10.1016/s0031-3955(16)38622-9

Source DB:  PubMed          Journal:  Pediatr Clin North Am        ISSN： 0031-3955            Impact factor:   3.278


  10 in total

1.  Inflammation in the developing human intestine: A possible pathophysiologic contribution to necrotizing enterocolitis.

Authors:  N N Nanthakumar; R D Fusunyan; I Sanderson; W A Walker
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

2.  Effects of omeprazole and gentamicin on the biochemical and histopathological alterations of the hypoxia/ reoxygenation induced intestinal injury in newborn rats.

Authors:  Unal Biçakçi; Burak Tander; Ender Aritürk; Birsen Kiliçoğlu Aydin; Oğuz Aydin; Riza Rizalar; Zafer Eren; Ferit Bernay
Journal:  Pediatr Surg Int       Date:  2005-10-21       Impact factor: 1.827

3.  First do no harm.

Authors:  Erika C Claud
Journal:  J Pediatr Pharmacol Ther       Date:  2012-10

4.  Duodenal microflora in very-low-birth-weight neonates and relation to necrotizing enterocolitis.

Authors:  C M Hoy; C M Wood; P M Hawkey; J W Puntis
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

5.  Neonatal Necrotizing Enterocolitis -Inflammation and Intestinal Immaturity.

Authors:  Erika C Claud
Journal:  Antiinflamm Antiallergy Agents Med Chem       Date:  2009-09

6.  Double blind, randomised, placebo controlled study of oral vancomycin in prevention of necrotising enterocolitis in preterm, very low birthweight infants.

Authors:  Y K Siu; P C Ng; S C Fung; C H Lee; M Y Wong; T F Fok; K W So; K L Cheung; W Wong; A F Cheng
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1998-09       Impact factor: 5.747

7.  Evaluation of low dose prostaglandin E1 treatment for ductus dependent congenital heart disease.

Authors:  H H Kramer; M Sommer; S Rammos; O Krogmann
Journal:  Eur J Pediatr       Date:  1995-09       Impact factor: 3.183

8.  Polyunsaturated fatty acid supplementation alters proinflammatory gene expression and reduces the incidence of necrotizing enterocolitis in a neonatal rat model.

Authors:  Jing Lu; Tamas Jilling; Dan Li; Michael S Caplan
Journal:  Pediatr Res       Date:  2007-04       Impact factor: 3.756

9.  Introducing multi-modal enteral medication reduced morbidity and mortality associated with necrotising enterocolitis.

Authors:  Arman Harutyunyan; Berndt Urlesberger; Armen Muradyan; Marine Hovhannisyan; Arman Badalyan; Hrant Kalenteryan; Emir Haxhija; Karine Sargsyan; Konstantin Yenkoyan; Ara Babloyan
Journal:  Acta Paediatr       Date:  2020-07-22       Impact factor: 2.299

10.  Synergistic protection of combined probiotic conditioned media against neonatal necrotizing enterocolitis-like intestinal injury.

Authors:  Sheng-Ru Shiou; Yueyue Yu; Yuee Guo; Shu-Mei He; C Haikaeli Mziray-Andrew; Jeanette Hoenig; Jun Sun; Elaine O Petrof; Erika C Claud
Journal:  PLoS One       Date:  2013-05-24       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.